📰 Third Bridge News
Page 97 - Third Bridge News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Third Bridge. Real-time updates on events, politics, business and more.
February 11, 2021
AstraZeneca's COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double supplies to more than 200 million doses per month by April.
February 11, 2021
AstraZeneca has seen its profits double in the past year as demand for cancer treatments surges and the companys time in the vaccine-packed spotlight rolls on
February 11, 2021
(This Feb 11 story corrects to show CEO was referring to vaccine production not efficacy in headline, first and 4th paragraphs)
February 11, 2021
<div class="at-above-post addthis_tool" data-url="https://www.metro.us/not-perfect-but-saves-2/"></div>(Reuters) – AstraZeneca’s COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double output by April and the African Union gave its backing for the shot. The two-dose inoculation, developed with Oxford University, has been hailed as a “vaccine [&helli...
February 11, 2021
<div class="at-above-post addthis_tool" data-url="https://www.metro.us/vaccine-production-not-perfect/"></div>(This Feb 11 story corrects to show CEO was referring to vaccine production not efficacy in headline, first and 4th paragraphs) (Reuters) – The production of AstraZeneca’s COVID-19 vaccine has not been perfect but the shot will have a big impact on the pandemic, its chief executive said on Thursday, as the drugmaker pledged to […]<!--...
February 11, 2021
Product sales at AstraZeneca jumped 10 per cent in 2020, up to nearly $26bn, in a year that made the at pharmaceutical company a household name.
February 11, 2021
AstraZeneca's Covid-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double output by April and the African Union gave its backing for the shot.
February 11, 2021
The pharmaceutical giant is ramping up production of the current Oxford/AstraZeneca to 200 million doses a month by April.
February 11, 2021
Read more about AstraZeneca sees growth picking up, even without Covid-19 vaccine on Business Standard. The pharma companys Q4 sales beat expectations, profit in line and expects to report Covid-19 vaccine sales from Q1